Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
MEI Pharma Inc (MEIP)  
$3.20 0.14 (4.58%) as of 4:30 Mon 5/6


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 66,620,000
Market Cap: 213.18(M)
Last Volume: 14,666 Avg Vol: 14,625
52 Week Range: $3.05 - $7.84
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:

    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   MEI Pharma is a late-stage pharmaceutical company focused on the development and commercialization of cancer therapies to improve outcomes for patients. Co.'s portfolio of drug candidates includes three clinical-stage assets, including: Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor; Voruciclib, an oral cyclin-dependent kinase 9 inhibitor; and ME-344, a mitochondrial inhibitor targeting the oxidative phosphorylation complex.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 336,100 417,600
Total Buy Value $0 $0 $2,112,595 $2,130,933
Total People Bought 0 0 2 3
Total Buy Transactions 0 0 6 7
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 113
  Page 5 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Rueckert William Dodge Director   –       •      –    2008-11-20 4 B $0.50 $425 D/D 849 20,849 2.31     -
   Rueckert William Dodge Director   –       •      –    2008-11-18 4 B $0.84 $8,366 D/D 10,000 20,000 2.39     -
   Novogen Ltd 10% Owner   –       –       •   2008-07-28 4 B $2.17 $6,311,000 D/D 2,908,295 52,408,295 2.45     -
   Williams Bryan Director   –       •      –    2008-03-13 4 B $2.52 $12,600 D/D 5,000 5,000 2.39     -
   Seaton David R CFO & Secretary   •       –      –    2008-03-13 4 B $2.20 $11,000 D/D 5,000 5,000 2.74     -
   Rueckert William Dodge Director   –       •      –    2008-03-08 4 B $2.25 $21,985 D/D 9,771 1,000 2.39     -
   Rueckert William Dodge Director   –       •      –    2008-03-07 4 B $2.20 $504 D/D 229 229 2.31     -
   Naughton Christopher CEO & President   •       •      –    2008-02-29 4 B $2.40 $8,640 I/I 3,600 5,000 2.58     -
   Naughton Christopher CEO & President   •       •      –    2008-02-27 4 B $2.40 $3,360 I/I 1,400 1,400 2.58     -
   Rueckert William Dodge Director   –       •      –    2007-12-21 4 S $2.50 $2,473 D/D (989) 0     -
   Rueckert William Dodge Director   –       •      –    2007-12-21 4 S $2.40 $26 D/D (11) 989     -
   Rueckert William Dodge Director   –       •      –    2007-03-27 3 IO $0.00 $0 D/D 0 1,000     -
   Novogen Ltd 10% Owner   –       –       •   2003-12-17 3 IO $0.00 $0 D/D 0 49,500,000     -

  113 Records found
  1  2  3  4  5    
  Page 5 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed